SPY468.11-0.17 -0.04%
DIA356.91-0.83 -0.23%
IXIC15,734.20+47.28 0.30%

Barclays Maintains Overweight on Adient, Lowers Price Target to $50

Barclays analyst Brian Johnson maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $53 to $50.

Benzinga · 11/11/2021 07:06
Barclays analyst Brian Johnson maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $53 to $50.